- Home
- ITRM vs PRT Comparison
ITRM vs PRT Comparison
Compare ITRM & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- PRT
- Stock Information
- Founded
- ITRM 2015
- PRT 2017
- Country
- ITRM Ireland
- PRT United States
- Employees
- ITRM N/A
- PRT N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- PRT Oil & Gas Production
- Sector
- ITRM Health Care
- PRT Energy
- Exchange
- ITRM Nasdaq
- PRT Nasdaq
- Market Cap
- ITRM 40.0M
- PRT 48.8M
- IPO Year
- ITRM 2018
- PRT N/A
- Fundamental
- Price
- ITRM $0.98
- PRT $4.09
- Analyst Decision
- ITRM Strong Buy
- PRT
- Analyst Count
- ITRM 2
- PRT 0
- Target Price
- ITRM $7.00
- PRT N/A
- AVG Volume (30 Days)
- ITRM 632.6K
- PRT 33.5K
- Earning Date
- ITRM 08-13-2025
- PRT 08-08-2025
- Dividend Yield
- ITRM N/A
- PRT 10.67%
- EPS Growth
- ITRM N/A
- PRT 6.25
- EPS
- ITRM N/A
- PRT 0.45
- Revenue
- ITRM N/A
- PRT $6,430,197.00
- Revenue This Year
- ITRM N/A
- PRT N/A
- Revenue Next Year
- ITRM $270.19
- PRT N/A
- P/E Ratio
- ITRM N/A
- PRT $9.06
- Revenue Growth
- ITRM N/A
- PRT 5.12
- 52 Week Low
- ITRM $0.81
- PRT $3.26
- 52 Week High
- ITRM $3.02
- PRT $4.63
- Technical
- Relative Strength Index (RSI)
- ITRM 47.37
- PRT 54.89
- Support Level
- ITRM $0.91
- PRT $3.91
- Resistance Level
- ITRM $1.28
- PRT $4.12
- Average True Range (ATR)
- ITRM 0.07
- PRT 0.10
- MACD
- ITRM 0.01
- PRT -0.01
- Stochastic Oscillator
- ITRM 18.48
- PRT 51.35
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.